Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
4.10 | 18287403 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
2.63 | 17418594 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.98 | 21441931 |
MESH:D000756 |
Anemia, Sideroblastic |
|
Manganese |
12.30 | 16910769 |
MESH:D000756 |
Anemia, Sideroblastic |
|
manganese chloride |
12.30 | 16910769 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
5.31 | 14601052 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
4.16 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
2.58 | 15136595 15993339 15668708 17369602 19526202 18234424 16115903 16322301 16096432 15634643 11325840 15994142 18628466 15692762 18382427 17983394 17426702 16595493 16935488 16826403 15939500 18695136 15567936 16264153 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
5.42 | 16051944 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
2.26 | 16234567 18059187 17876044 16023760 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
3.30 | 1485588 16201981 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
2.71 | 6189445 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.74 | 17131338 16278810 15476868 17007740 17329180 17924179 16109756 17928571 16364871 16731534 15505089 15811867 17351982 16952015 16269455 17974986 17308081 17382496 18627295 16612575 16242529 16651473 16455267 15792986 17519947 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
3.04 | 17334414 16243910 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.15 | 18259882 18802399 |
OMIM:605594 |
DEAFNESS, AUTOSOMAL DOMINANT 39, WITH DENTINOGENESIS IMPERFECTA 1 |
marker/mechanism |
|
| |
OMIM:125420 |
DENTIN DYSPLASIA, TYPE II |
marker/mechanism |
|
| |
MESH:D003811 |
Dentinogenesis Imperfecta |
marker/mechanism |
|
| |
MESH:C538216 |
Dentinogenesis imperfecta, shields type 3 |
marker/mechanism |
|
| |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
2.52 | 17416283 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
3.93 | 18602426 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
3.67 | 17359293 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.77 | 18037988 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
5.13 | 19069698 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
8.30 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
Manganese |
8.30 | 17043766 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
3.75 | 15692506 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.72 | 16879835 16330681 17875725 16244372 18006777 18674790 16495754 16707910 12587719 16144979 16244371 17888722 14766674 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
3.54 | 17481944 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
4.27 | 15692506 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
3.73 | 17606976 15147373 18501091 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
3.23 | 16775033 15699352 15369732 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.53 | 16707910 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.77 | 16085563 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
2.15 | 16595196 16439617 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
7.04 | 17085340 16842330 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
kojic acid |
7.04 | 18544905 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
2.15 | 17418594 6189445 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.70 | 16098063 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
4.09 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
5.05 | 15621674 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
3.24 | 15458769 |
MESH:D020149 |
Manganese Poisoning |
|
Manganese |
6.13 | 16568477 16551646 19453300 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
2.32 | 16827129 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
3.17 | 17638057 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.87 | 15792986 |
MESH:D009069 |
Movement Disorders |
|
Manganese |
5.41 | 16551646 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
5.33 | 17415656 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
3.07 | 15857846 19429709 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
3.07 | 18259882 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
5.25 | 16899518 16636307 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
4.33 | 16889571 15640375 |
MESH:D009410 |
Nerve Degeneration |
|
Manganese |
4.55 | 16551646 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.42 | 15555623 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.40 | 15930896 |
MESH:D010300 |
Parkinson Disease |
|
Manganese |
3.47 | 11181820 |
MESH:D020734 |
Parkinsonian Disorders |
|
Manganese |
4.82 | 16140633 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.77 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.77 | 17638057 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
3.50 | 18437689 15749863 15897917 16868541 16729912 16888761 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.70 | 17922066 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
4.34 | 15675481 17203757 16767912 17710206 15625365 18313854 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.68 | 14601052 16326096 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
5.33 | 17846226 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
3.09 | 15692506 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
5.05 | 17203757 16767912 15625365 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
3.64 | 17909728 16010429 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
2.87 | 17653716 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.70 | 17334414 17638931 17678736 16364871 |